RA

Rakesh Ahuja

Active Director Director DIN 09144227
DIN 09144227 First appointment Apr 2021 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value •••• Premium profile

About Rakesh Ahuja

Data last updated:

Rakesh Ahuja is a Director at New India Biopharma Private Limited (since 2021). The company operates in Financial Services. New India Biopharma Private Limited reported revenue of ₹1.62 Cr (FY 2025).

DIN 09144227
Primary Designation Director
Industry Financial Services
First Appointment 13 Apr 2021
Oldest Company Age 15 yrs
Largest company New India Biopharma Private Limited · ₹1.62 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
New India Biopharma Private Limited U51397DL2011PTC215424
Director13 Apr 20212011₹1.62 Cr (FY 2025)Active

Board colleagues of Rakesh Ahuja

Directorship timeline

Open interactive timeline →
New India Biopharma Private Limited
Premium access

Shareholding and investment profile for Rakesh Ahuja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Ahuja

Rakesh Ahuja currently holds 1 directorship: New India Biopharma Private Limited (Director, since 13 Apr 2021, revenue ₹1.62 Cr (FY 2025)).

Rakesh Ahuja was first appointed on 13 Apr 2021 as Director at New India Biopharma Private Limited.

The current boards of Rakesh Ahuja's companies include Nergish Dadi Mistry (New India Biopharma Private Limited), Randeep Jaikaria Singh (New India Biopharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available